Marcus, D M
Singh, H
Fechter, C M
Chamberlain, D P
Article History
Received: 24 February 2015
Accepted: 6 June 2015
First Online: 4 September 2015
Competing interests
: DMM is a consultant for Genentech, Inc., Regeneron, and Thrombogenics. DMM and HS have received clinical research support from Acucela, Alcon, Allergan, Genentech, Inc., GlaxoSmithKline, Ophthotech, Pfizer, Regeneron, and Thrombogenics. The remaining authors declare no conflict of interest.